GDOC Top Holdings & Constituents
GDOC, offered by Goldman Sachs, holds 39 reported positions across $19.3M in assets. Its largest holdings are Eli Lilly & Co (LLY) (11.98%), Boston Scientific Corp (BSX) (6.98%), and Johnson & Johnson (JNJ) (6.13%). The 5 biggest positions account for 36.08% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
LLY Eli Lilly & Co | 11.98% | $2.67M |
BSX Boston Scientific Corp | 6.98% | $1.56M |
JNJ Johnson & Johnson | 6.13% | $1.37M |
TMO Thermo Fisher Scientific Inc | 5.54% | $1.23M |
AZN AstraZeneca PLC | 5.45% | $1.22M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Nov 30, 2025. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.